Prokidney confirms phase 3 program for autologous kidney cell therapy react®

Two phase 3 controlled trials with substantially similar design to enroll 1,200 subjects with diabetic ckd two phase 3 controlled trials with substantially similar design to enroll 1,200 subjects with diabetic ckd

PROK Ratings Summary

PROK Quant Ranking